Table 2 Seventeen genes differentially expressed between stage II vs. stage III high-grade serous ovarian cancer (HGSOC) samples

TSPAN1

chr1:46640748–46651634

94.34

22.3

5.38

5.46

17.55

5.20x10⁻⁴

ANK1

chr8:41510743–41754280

0.46

0.18

0.04

0.06

10.18

6.61x10⁻³

SERPINE2

chr2:224839764–224904036

68.45

45.04

7.46

6.57

9.18

3.98x10⁻²

SYNPO

chr5:149980641–150038792

46.57

20.07

5.24

4.47

8.89

9.24x10⁻³

PDGFC

chr4:157682762–157892546

30

18.76

3.77

0.85

7.95

3.42x10⁻²

NQO1

chr16:69743303–69760533

20.81

9.36

2.79

1.59

7.45

1.14x10⁻²

CA12

chr15:63615729–63674075

30.59

8.42

4.41

3.49

6.94

2.25x10⁻³

PPP1R14C

chr6:150464187–150571528

4.32

1.04

0.63

0.23

6.86

8.60x10⁻⁴

TMEM30B

chr14:61744088–61748530

14.47

4.55

2.2

1

6.59

2.96x10⁻³

PGK1

chrX:77359665–77382324

147.96

70.15

25.3

10.29

5.85

1.62x10⁻²

DNAJB9

chr7:108210188–108215294

13.32

8.54

2.45

0.76

5.45

4.70x10⁻²

CLIC1

chr6:31698357–31704341

236.93

57.2

48.63

6.54

4.87

1.08x10⁻³

ECE1

chr1:21543739–21672034

25.1

4.53

5.67

3.03

4.42

1.00x10⁻³

ENPP4

chr6:46097700–46114436

3.17

0.88

0.74

0.35

4.26

3.71x10⁻³

ZDHHC7

chr16:85008066–85045141

26.42

14.78

6.32

2.57

4.18

4.02x10⁻²

GCLC

chr6:53362139–53409927

9.83

3.68

2.39

0.75

4.11

9.78x10⁻³

CHST15

chr10:125767181–125853123

13.95

0.82

3.57

1.39

3.9

9.00x10⁻⁵